Integrative Therapeutics, Inc.   Report issue

For profit Phase 2
Founded: Green Bay WI United States (2000)
Status: Left NME R&D (2019)

Organization Overview

First Clinical Trial
2009
NCT01108549
First Marketed Drug
None
First NDA Approval
None
Last Known Activity
2009

Timeline

NOW
  • Now

Alternative names

Integrative Therapeutics, Inc.

Active Ingredients

Drugs in Phase 2 Trials (2)

coconut oil (1 trial)

peppermint extract (1 trial)

Drugs in Other Trials (1)

d-ribose (1 trial)

Indications

Overview

  • Highest Phase: Phase 2
  • # of Trials: 2
  • # of Trial APIs: 3